- Home
- RS vs RVNC Comparison
RS vs RVNC Comparison
Compare RS & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RS
- RVNC
- Stock Information
- Founded
- RS 1939
- RVNC 1999
- Country
- RS United States
- RVNC United States
- Employees
- RS N/A
- RVNC N/A
- Industry
- RS Metal Fabrications
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- RS Industrials
- RVNC Health Care
- Exchange
- RS Nasdaq
- RVNC Nasdaq
- Market Cap
- RS 15.5B
- RVNC 320.5M
- IPO Year
- RS 1994
- RVNC 2014
- Fundamental
- Price
- RS $269.09
- RVNC $3.09
- Analyst Decision
- RS Hold
- RVNC Hold
- Analyst Count
- RS 5
- RVNC 9
- Target Price
- RS $344.00
- RVNC $8.45
- AVG Volume (30 Days)
- RS 352.1K
- RVNC 3.6M
- Earning Date
- RS 02-13-2025
- RVNC 11-07-2024
- Dividend Yield
- RS 1.64%
- RVNC N/A
- EPS Growth
- RS N/A
- RVNC N/A
- EPS
- RS 18.25
- RVNC N/A
- Revenue
- RS $14,045,700,000.00
- RVNC $256,945,000.00
- Revenue This Year
- RS N/A
- RVNC $11.28
- Revenue Next Year
- RS $1.34
- RVNC $27.21
- P/E Ratio
- RS $14.74
- RVNC N/A
- Revenue Growth
- RS N/A
- RVNC 25.82
- 52 Week Low
- RS $261.16
- RVNC $2.30
- 52 Week High
- RS $342.20
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- RS 26.58
- RVNC 33.47
- Support Level
- RS $302.62
- RVNC $3.06
- Resistance Level
- RS $310.14
- RVNC $3.09
- Average True Range (ATR)
- RS 7.47
- RVNC 0.11
- MACD
- RS -5.49
- RVNC 0.02
- Stochastic Oscillator
- RS 12.96
- RVNC 6.90
About RS Reliance Steel & Aluminum Co. (DE)
Reliance Inc is a diversified metal solutions provider and metals service center company. It provides value-added metals processing services and distributes.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.